Flipping Book

Jiang ZQ, IJRBOP 2012; 83: 332-339

Long term clinical outcomes of IMRT in NSCLC

Update of the MD Anderson experience: 165 patients 2005-2006

66Gy in 33fx

Median survival 21.6 months

Esophageal Tox G3

G2: 70%

G3: 18% - 7/29 stricture

Lung Tox G3: 11% 6m;

14% 12m

Lung Tox G2

Lung Tox G1: at 18m

86%